IDH1 mutation and MGMT methylation status predict survival in patients with anaplastic astrocytoma treated with temozolomide-based chemoradiotherapy

Giuseppe Minniti, Claudia Scaringi, Antonella Arcella, Gaetano Lanzetta, Domenica Di Stefano, Stefania Scarpino, Alessandro Bozzao, Andrea Pace, Veronica Villani, Maurizio Salvati, Vincenzo Esposito, Felice Giangaspero, Riccardo Maurizi Enrici

Research output: Contribution to journalArticlepeer-review

Fingerprint

Dive into the research topics of 'IDH1 mutation and MGMT methylation status predict survival in patients with anaplastic astrocytoma treated with temozolomide-based chemoradiotherapy'. Together they form a unique fingerprint.

Medicine & Life Sciences